Innovassynth

Comprehensive Internet Overview with AI

• Company Overview & Core Business:
  • Name: Innovassynth Technologies (India) Ltd. (formerly Chemicals Division of Indian Organic Chemicals).
  • Founding: Established in 1964, incorporated as Innovassynth Technologies (I) Limited in 2001.
  • Primary Business: A Custom Development & Manufacturing Organization (CDMO) providing contract research, custom synthesis, and contract manufacturing services.
  • Key Segments: Pharma intermediates, protected nucleosides and amidites, protected amino acids for peptide synthesis, fine chemicals, nutraceuticals, Organometallics, catalysts for polymer and petrochemical applications, Flavours & Fragrances, Electronics & Battery chemicals.
  • Global Reach: Trusted partner to numerous global Pharmaceutical, Life Sciences, Chemicals, and Material Science organizations, with over 45 customers in USA, Europe, and Japan.
  • Infrastructure: Boasts over 60 acres of world-class infrastructure, including manufacturing plants (Khopoli) and headquarters in Pune (Hinjewadi).
  • R&D Capability: Strong R&D infrastructure with a state-of-the-art facility (24,000 Sq. ft.), 9 labs, 60 fume hoods, and a team of 100+ scientists (including 20+ PhDs) and 200+ technical staff.
  • Manufacturing Capacity: Over 10 lines with a total reaction capacity of 250+ KL, including pilot, medium-scale, and multipurpose plants.
  • Certifications: ISO 9001:2000, ISO 9001:2008 (older certifications, likely updated to current ISO 9001:2015), and moving towards US FDA approval for its cGMP pilot plant.
• Pune, Maharashtra Presence:
  • Pune Address: TCG International Biotech Park, 2nd Floor, Genesis Square, Hinjewadi Phase-II, Pune, Maharashtra, India - 411057.
  • This location appears to be their headquarters/corporate office, housing R&D and administrative functions. The manufacturing plant is primarily in Khopoli, Raigad, Maharashtra.
  • Contact: +91 20 61921000.
• Services and Products:
  • Custom Research & Development: Offers bespoke research and development services tailored to customer requirements.
  • Contract Manufacturing: Comprehensive manufacturing services including process development, technology transfer, scale-up, and commercialization.
  • FTE/Fee for Services: Provides Full Time Equivalent or Fee for Services models.
  • Key Product Categories:
    • Nucleosides (Protected Nucleosides, Phosphoramidites, Reagents, Delivery Platforms like GalNAc).
    • Pharma Intermediates (e.g., 4-Butyl Resorcinol, 2-Amino Benzonitrile).
    • Organometallics, including pre-catalysts for metallocene, ZN catalysts, and donors.
    • Polymers additives.
    • ALD/CVD precursors, donors & ligands (for semiconductors).
    • Flavours & Fragrances.
    • Agro Intermediates.
    • Various industrial chemicals and organic compounds (e.g., Isopropyl Bromide, Chloroacetyl Chloride, Acetyl Bromide, Trityl Chloride).
• Employee Reviews & Work Environment (primarily from Justdial insights for factory location):
  • Positive Aspects:
    • "Supportive and helpful faculty and management."
    • "Professional environment and good place for career growth."
    • "Good company culture for new employees."
    • "Emphasis on learning and development."
    • "Care for employees during the pandemic."
  • General Sentiment: While detailed Glassdoor/Indeed reviews for the Pune location specifically are not widely available, insights from the factory location (Khopoli) on Justdial suggest a generally positive employee perception regarding support, professional growth, and company culture.
  • Recruitment: Occasionally posts for roles like R&D freshers, indicating opportunities.
• Customer & Partner Sentiment (from Business Directories & Industry Reports):
  • Customer-Centric Approach: Innovassynth emphasizes its customer-centric approach, focusing on process optimization, scale-up, quality, safety, and cost-effectiveness.
  • IP Protection and Data Security: Highlighted as a core commitment, ensuring data integrity and intellectual property protection.
  • Credibility and Reliability: Their long-standing relationships with key customers and partnerships with global pharma and life sciences companies attest to their reliability.
  • Financial Stability: ICRA ratings reports indicate a comfortable capital structure and adequate liquidity, contributing to their standing as a stable partner.
  • Industry Competition: Acknowledged as a moderate-sized player in a highly competitive CRAMS sector, facing pricing pressures from larger players. However, established customer relationships provide some comfort.
  • Supply Chain: Committed to a transparent supply chain and robust quality management systems.
• Social Media & Online Presence:
  • Professional Platforms: Maintains a presence on professional platforms like LinkedIn (Innovassynth Technologies) where they share company updates, news, and career opportunities.
  • Industry-Specific Platforms: Features on platforms like CPHI Online and PharmaSource, showcasing their CDMO services and product offerings to industry peers and potential partners.
  • Limited Direct Consumer/Product Reviews: As a B2B (Business-to-Business) company, there are no e-commerce product reviews (Amazon, Flipkart) or extensive direct consumer reviews/comments on general social media (Facebook, Instagram, YouTube, TikTok) as would be typical for a B2C company.
  • News Coverage: Appears in financial news (e.g., related to their stock performance under Innovassynth Investments Ltd. or rating reports from ICRA) and industry news related to chemical and pharmaceutical manufacturing.